Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Jeanine M. Genkinger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-8438-0412; OpenAlex author ID A5018554532. Sources: OpenAlex.

Their work

Papers
24 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
121
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: 2 papers · 2024: 3 papers · 2025: 3 papers · 2026: 2 papers

Papers 24

  1. Adherence to the Mediterranean diet and risk of pancreatic cancer: an analysis of 2.3 million participants in the Pooling Project of Prospective Studies of Die… Last author DOI 10.1007/s10654-026-01418-x↗
  2. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  3. Why Is Earlier Detection, the Key to Reducing Pancreatic Cancer, So Challenging Despite Technological Advances? Co-author DOI 10.1200/jco-25-00796↗
  4. Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. Co-author DOI 10.1371/journal.pmed.1004590↗
  5. Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2025.1501943↗
  6. Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy. Co-author DOI 10.1002/jso.27851↗
  7. Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies. Co-author DOI 10.1016/j.pan.2024.10.012↗
  8. Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer. Co-author DOI 10.1136/gutjnl-2023-331074↗
  9. A blood-based metabolomic signature predictive of risk for pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2023.101194↗
  10. Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer Co-author DOI 10.1101/2023.03.19.533333↗
  11. Sustained Weight Loss, Weight Cycling, and Weight Gain During Adulthood and Pancreatic Cancer Incidence in the Women's Health Initiative. Last author DOI 10.1093/aje/kwac016↗
  12. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. Co-author DOI 10.1053/j.gastro.2020.11.052↗
  13. Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression. Co-author DOI 10.1136/gutjnl-2019-319912↗
  14. Influence of KRAS mutations, persistent organic pollutants, and trace elements on survival from pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.envres.2020.109781↗
  15. Identifying Novel Genetic Markers Through a Transcription-Wide Association Study: Can This Be a Path to Reducing the Burden of Pancreatic Cancer? Co-author DOI 10.1093/jnci/djz247↗
  16. Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes. Co-author DOI 10.1136/gutjnl-2018-317706↗
  17. Transcriptional deconvolution reveals consistent functional subtypes of pancreatic cancer epithelium and stroma Co-author DOI 10.1101/288779↗
  18. CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations. Co-author DOI 10.1158/1055-9965.epi-17-1065↗
  19. Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening Program. Last author DOI 10.1007/s10897-016-0057-4↗
  20. Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Co-author DOI 10.1093/annonc/mdv355↗
  21. Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Co-author DOI 10.1093/annonc/mdu019↗
  22. Intake of fruits and vegetables and risk of pancreatic cancer in a pooled analysis of 14 cohort studies. Co-author DOI 10.1093/aje/kws027↗
  23. Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Co-author DOI 10.1158/1055-9965.epi-11-0945-t↗
  24. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Co-author DOI 10.1002/ijc.25794↗

Closest collaborators

The 25 strongest of 121 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John A. Chabot · 6 shared papers, 2018–2024 · strength 0.71
  2. Michael D. Kluger · 4 shared papers, 2021–2024 · strength 0.56
  3. Brian Matthew Wolpin · 5 shared papers, 2015–2024 · strength 0.54
  4. Alison P. Klein · 1 shared paper, 2025 · strength 0.54
  5. Alina Cornelia Iuga · 4 shared papers, 2018–2023 · strength 0.38
  6. Kenneth P. Olive · 4 shared papers, 2018–2023 · strength 0.38
  7. Ana Babić · 3 shared papers, 2021–2024 · strength 0.35
  8. Andrea J. Bullock · 3 shared papers, 2021–2024 · strength 0.35
  9. Ehsan Irajizad · 3 shared papers, 2021–2024 · strength 0.35
  10. Thomas E. Clancy · 3 shared papers, 2021–2024 · strength 0.35
  11. Kimmie Ng · 3 shared papers, 2021–2024 · strength 0.35
  12. Johannes Francois Fahrmann · 3 shared papers, 2021–2024 · strength 0.35
  13. Samir Hanash · 3 shared papers, 2021–2024 · strength 0.35
  14. Anirban Maitra · 3 shared papers, 2021–2024 · strength 0.35
  15. Kunal Jajoo · 3 shared papers, 2021–2024 · strength 0.35
  16. Fay Kastrinos · 3 shared papers, 2021–2024 · strength 0.35
  17. Gulam Abbas Manji · 2 shared papers, 2023–2024 · strength 0.34
  18. Qiao-Li Wang · 2 shared papers, 2024 · strength 0.29
  19. H. Carlo Maurer · 3 shared papers, 2018–2023 · strength 0.28
  20. Andrea Califano · 3 shared papers, 2018–2023 · strength 0.28
  21. Thomas E. Rohan · 5 shared papers, 2011–2022 · strength 0.26
  22. Stephanie A. Smith‐Warner · 5 shared papers, 2011–2022 · strength 0.26
  23. Jody V. Vykoukal · 2 shared papers, 2021–2023 · strength 0.22
  24. Emmanuel Zorn · 1 shared paper, 2025 · strength 0.21
  25. Talita Ferreira Marques Aguiar · 1 shared paper, 2025 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.